Stock Financial Ratios, Dividends, Split History

AAT / American Assets Trust Inc financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price38.21
Volume211,500.00
Market Cap ($M)1,768.24
Enterprise Value ($M)1,711.65
Book Value ($M)823.04
Book Value / Share17.44
Price / Book2.14
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Common Shares Outstanding2 0
Common Shares Outstanding 47,204,588
Weighted Average Number Of Diluted Shares Outstanding 64,087,250
Weighted Average Number Of Shares Outstanding Basic 46,715,520
Preferred Stock Shares Outstanding 0
Scoring Models
Piotroski F-Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.02
Return on Assets (ROA)0.02
Return on Equity (ROE)0.05
Balance Sheet (mrq) ($M)
Assets2,213.57
Liabilities1,384.23
Quick Ration/a
Current Ration/a
Income Statement (mra) ($M)
Revenue From Leased And Owned Hotels39,545,000.00
Revenues From Transactions With Other Operating Segments Of Same Entity0.00
Revenues314,983,000.00
Real Estate Revenue Net0.00
Property Management Fee Revenue0.00
Other Real Estate Revenue16,180,000.00
Management Fees Revenue0.00
Other Real Estate Rental Revenue1,667,000.00
Operating Income93.65
Net Income40.13
Earnings Per Share Diluted0.62
Earnings Per Share Basic0.62
Cash Flow Statement (mra) ($M)
Cash From Operations145.85
Cash from Investing-330.56
Cash from Financing-330.56
Identifiers and Descriptors
CUSIP024013104
Central Index Key (CIK)1500217

Split History

Stock splits are used by American Assets Trust Inc to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Fourteen More Philanthropists Join The Gates-Buffett Giving Pledge

2018-05-31 forbes
On Wednesday, the Giving Pledge announced that 14 more philanthropists joined its ranks in the last year, committing to donate more than half of their wealth to charitable causes. The newest signatories hail from Canada, India, the United Arab Emirates and the United States. To date, 183 individuals from 22 countries have signed the pledge. (5-0)

American Assets Trust's (AAT) CEO Ernest Rady on Q1 2018 Results - Earnings Call Transcript

2018-05-03 seekingalpha
American Assets Trust, Inc. (NYSE:AAT) Q1 2018 Results Earnings Conference Call May 2, 2018 11:00 AM ET (14-0)

REIT Portfolio - March 2018: 6th Consecutive Month Of Outperformance

2018-04-11 seekingalpha
We recently added a 4% allocation to Single Family Homes and made a portfolio management decision to eliminate Diversified REITs from the portfolio indefinitely. (45-0)

Bear of the Day: Kimco Realty (KIM)

2018-04-10 zacks
Today’s Bear of the Day lies at the epicenter of two strong trends which are bearish for the company. Those trends are interest rates on the rise and the death of the retail. While the bad news for retail may be overblown, there’s no question that malls in America are going to have to adapt to get back to the levels of success they’ve seen in the past. Interest rates certainly will rise, putting pressure on REITs and other income-producing equities. (12-0)

CUSIP: 024013104